Sign Up to like & get
recommendations!
1
Published in 2022 at "Environmental Toxicology and Chemistry"
DOI: 10.1002/etc.5503
Abstract: Methods for extrapolating measured in vitro intrinsic clearance to a whole‐body biotransformation rate constant (kB) have been developed to support modeled bioaccumulation assessments for fish. The inclusion of extrapolated kB values into existing bioaccumulation models…
read more here.
Keywords:
predict chemical;
volume distribution;
biotransformation;
used predict ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.2220
Abstract: Monalizumab is a novel, first-in-class humanized immunoglobulin G (IgG)-4 monoclonal antibody (mAb) immune checkpoint inhibitor that targets the inhibitory CD94/NKG2A receptors. The objectives of this analysis were to develop a population pharmacokinetic (PK) model of…
read more here.
Keywords:
volume distribution;
patients advanced;
population pharmacokinetics;
solid tumors ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "European Journal of Clinical Pharmacology"
DOI: 10.1007/s00228-019-02657-6
Abstract: AimThere is accumulating evidence that neutropenic patients require higher dosages of vancomycin. To prevent sub-therapeutic drug exposure, it is of utmost importance to obtain adequate exposure from the first dose onwards. We aimed to quantify…
read more here.
Keywords:
effect neutropenia;
volume distribution;
patients known;
pharmacokinetics vancomycin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "European Journal of Pharmaceutical Sciences"
DOI: 10.1016/j.ejps.2017.05.032
Abstract: Abstract NNZ‐2566 is a novel, small molecule being developed as a treatment for cognitive impairment in different CNS conditions, including Rett and Fragile‐X syndrome, both of which are associated with moderate to severe neurodevelopmental disorder.…
read more here.
Keywords:
volume distribution;
pharmacokinetics nnz;
population pharmacokinetics;
healthy subjects ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Alloys and Compounds"
DOI: 10.1016/j.jallcom.2018.08.148
Abstract: Abstract The structure of Ni 50 V 50 amorphous alloy was investigated by using neutron, X-ray diffraction and reverse Monte Carlo (RMC) modelling. The RMC configuration was decomposed into polyhedral holes whose faces are all…
read more here.
Keywords:
polyhedral holes;
distribution structural;
volume distribution;
free volume ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Environmental science & technology"
DOI: 10.1021/acs.est.2c03421
Abstract: Chemicals with elevated bioaccumulation profiles present potential hazards to public health and the environment. Ionizable organic compounds (IOCs) increasingly represent a large proportion of commercial chemicals; however, historical approaches for bioaccumulation determinations are mainly developed…
read more here.
Keywords:
volume distribution;
apparent volume;
ionizable organic;
bioaccumulation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Drug Metabolism and Disposition"
DOI: 10.1124/dmd.120.000337
Abstract: Volume of distribution (Vd) is a primary pharmacokinetic parameter used to calculate the half-life and plasma concentration-time profile of drugs. Numerous models have been relatively successful in predicting Vd, but the model developed by Korzekwa…
read more here.
Keywords:
tissue binding;
volume distribution;
plasma protein;
model ... See more keywords